| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
|
156,914 |
140,506 |
$21.99M |
| 99214 |
|
134,785 |
122,018 |
$18.52M |
| G9005 |
Coordinated care fee, risk adjusted maintenance |
38,415 |
38,415 |
$11.69M |
| 99215 |
Prolong outpt/office vis |
34,298 |
32,622 |
$4.86M |
| 80053 |
|
47,467 |
43,584 |
$2.45M |
| Q3014 |
Telehealth originating site facility fee |
42,203 |
35,326 |
$2.44M |
| 99393 |
|
14,296 |
14,105 |
$2.09M |
| 99392 |
|
13,353 |
13,342 |
$2.00M |
| 90832 |
|
15,699 |
10,336 |
$1.95M |
| 99212 |
|
14,541 |
13,836 |
$1.86M |
| 99391 |
|
11,543 |
10,741 |
$1.77M |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
23,907 |
22,997 |
$1.72M |
| 45380 |
|
1,495 |
1,484 |
$1.62M |
| 90834 |
|
9,397 |
6,370 |
$1.44M |
| 43239 |
|
1,844 |
1,832 |
$1.39M |
| 99395 |
|
9,401 |
9,335 |
$1.31M |
| 99394 |
|
8,936 |
8,921 |
$1.29M |
| 99283 |
|
6,681 |
6,487 |
$1.27M |
| 74177 |
|
2,405 |
2,366 |
$1.21M |
| 99285 |
|
6,805 |
6,483 |
$1.19M |
| 99396 |
|
8,238 |
8,185 |
$1.14M |
| 87635 |
|
24,807 |
23,183 |
$1.13M |
| 81025 |
|
14,812 |
14,279 |
$1.08M |
| 87502 |
|
11,819 |
11,119 |
$1.02M |
| 93306 |
|
2,523 |
2,520 |
$950K |
| 96127 |
|
28,067 |
13,900 |
$935K |
| 99284 |
|
4,292 |
4,134 |
$777K |
| 20610 |
|
2,880 |
2,767 |
$756K |
| 45378 |
|
666 |
661 |
$700K |
| 80048 |
|
13,313 |
11,900 |
$647K |
| 90686 |
|
26,833 |
26,242 |
$636K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
21,469 |
16,444 |
$595K |
| 45385 |
|
773 |
766 |
$580K |
| 96365 |
|
4,218 |
3,212 |
$566K |
| 96413 |
|
3,710 |
2,137 |
$536K |
| 82306 |
|
17,088 |
17,025 |
$523K |
| 80061 |
|
27,534 |
27,398 |
$517K |
| 99211 |
|
12,599 |
10,366 |
$514K |
| 87491 |
|
9,779 |
9,665 |
$474K |
| 88305 |
|
10,377 |
7,440 |
$470K |
| 59025 |
|
2,686 |
1,735 |
$453K |
| 77067 |
|
6,209 |
6,188 |
$442K |
| 76856 |
|
1,829 |
1,808 |
$438K |
| 97110 |
|
6,511 |
2,569 |
$412K |
| 70450 |
|
1,066 |
1,048 |
$411K |
| 80307 |
|
8,674 |
7,453 |
$410K |
| 85025 |
|
55,667 |
49,374 |
$401K |
| 17110 |
|
1,487 |
1,377 |
$400K |
| 86850 |
|
4,362 |
4,043 |
$362K |
| 96361 |
|
1,715 |
1,571 |
$353K |
| 84443 |
|
33,202 |
32,724 |
$343K |
| 90791 |
|
1,485 |
1,409 |
$295K |
| 99282 |
|
1,433 |
1,395 |
$284K |
| 74176 |
|
537 |
525 |
$280K |
| 87507 |
|
1,153 |
1,142 |
$276K |
| 87651 |
|
5,947 |
4,991 |
$274K |
| 96372 |
|
11,911 |
10,179 |
$271K |
| 36416 |
|
3,083 |
3,033 |
$261K |
| 36415 |
|
39,087 |
15,317 |
$259K |
| 77063 |
|
5,732 |
5,698 |
$249K |
| 90792 |
|
977 |
975 |
$246K |
| 90651 |
|
5,536 |
5,225 |
$231K |
| 87624 |
|
4,608 |
4,600 |
$229K |
| 76816 |
|
2,698 |
2,592 |
$228K |
| 90715 |
|
8,407 |
8,367 |
$221K |
| 76830 |
|
2,137 |
2,117 |
$214K |
| 93017 |
|
1,115 |
1,107 |
$206K |
| 93005 |
|
12,218 |
11,285 |
$206K |
| J1050 |
Injection, medroxyprogesterone acetate, 1 mg |
3,471 |
3,468 |
$202K |
| 87798 |
|
2,949 |
1,652 |
$202K |
| 76705 |
|
1,966 |
1,949 |
$201K |
| 78452 |
|
287 |
284 |
$199K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
7,971 |
5,645 |
$198K |
| 70553 |
|
317 |
317 |
$194K |
| 87591 |
|
9,766 |
9,664 |
$193K |
| 96375 |
|
4,628 |
3,473 |
$192K |
| 78815 |
|
259 |
259 |
$190K |
| 52000 |
|
103 |
103 |
$189K |
| 80051 |
|
4,763 |
4,577 |
$183K |
| J9271 |
Injection, pembrolizumab, 1 mg |
16 |
12 |
$181K |
| 88175 |
|
5,491 |
5,479 |
$174K |
| 87880 |
|
16,420 |
14,295 |
$173K |
| 71046 |
|
5,136 |
5,036 |
$169K |
| J7298 |
Levonorgestrel-releasing intrauterine contraceptive system (mirena), 52 mg |
182 |
181 |
$169K |
| 76770 |
|
866 |
861 |
$161K |
| 92012 |
|
2,537 |
1,921 |
$158K |
| 90670 |
|
7,355 |
7,335 |
$157K |
| 96366 |
|
916 |
644 |
$148K |
| 81420 |
|
237 |
235 |
$147K |
| 73630 |
|
3,347 |
3,189 |
$147K |
| 90648 |
|
6,803 |
6,791 |
$139K |
| 73564 |
|
2,341 |
2,285 |
$139K |
| 96360 |
|
895 |
778 |
$138K |
| 73610 |
|
2,613 |
2,440 |
$137K |
| 93971 |
|
983 |
967 |
$128K |
| 83036 |
|
22,088 |
21,932 |
$125K |
| 90677 |
|
2,889 |
2,884 |
$124K |
| 76801 |
|
1,078 |
1,058 |
$122K |
| 94010 |
|
1,294 |
1,282 |
$122K |
| 92557 |
|
2,681 |
2,374 |
$119K |
| 76536 |
|
1,088 |
1,086 |
$117K |
| G0483 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed |
528 |
522 |
$115K |
| 90680 |
|
5,739 |
5,727 |
$112K |
| 92567 |
|
3,393 |
3,373 |
$104K |
| 90700 |
|
4,555 |
4,547 |
$103K |
| G0378 |
Hospital observation service, per hour |
2,217 |
1,352 |
$103K |
| 76805 |
|
894 |
890 |
$103K |
| 99385 |
|
811 |
807 |
$103K |
| 72110 |
|
1,435 |
1,424 |
$103K |
| 97162 |
|
933 |
927 |
$102K |
| 87634 |
|
3,949 |
3,862 |
$99K |
| 90633 |
|
4,724 |
4,716 |
$99K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
2,116 |
611 |
$97K |
| 73721 |
|
163 |
162 |
$97K |
| 82607 |
|
9,777 |
9,687 |
$96K |
| 87081 |
|
14,451 |
14,108 |
$92K |
| 99406 |
|
3,489 |
3,447 |
$92K |
| 71271 |
|
291 |
291 |
$91K |
| 64493 |
|
63 |
62 |
$90K |
| A9552 |
Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries |
336 |
336 |
$89K |
| 77336 |
|
259 |
114 |
$89K |
| 90723 |
|
4,801 |
4,783 |
$89K |
| 86901 |
|
4,417 |
4,091 |
$89K |
| 87661 |
|
4,303 |
4,224 |
$88K |
| 92134 |
|
1,552 |
1,516 |
$86K |
| 83655 |
|
7,245 |
7,112 |
$85K |
| 51798 |
|
312 |
307 |
$84K |
| 73030 |
|
2,035 |
1,959 |
$82K |
| 82728 |
|
7,932 |
7,653 |
$81K |
| 84439 |
|
9,722 |
9,577 |
$78K |
| 96374 |
|
4,019 |
3,810 |
$76K |
| 87481 |
|
1,824 |
1,796 |
$75K |
| 85027 |
|
13,026 |
12,342 |
$74K |
| 71275 |
|
149 |
149 |
$73K |
| 73110 |
|
1,736 |
1,606 |
$73K |
| 95004 |
|
216 |
216 |
$73K |
| 86900 |
|
4,421 |
4,095 |
$73K |
| 90734 |
|
3,229 |
3,221 |
$70K |
| 73130 |
|
1,161 |
1,118 |
$70K |
| 76700 |
|
365 |
365 |
$70K |
| 87086 |
|
13,693 |
13,039 |
$70K |
| 88304 |
|
2,142 |
1,785 |
$70K |
| 83970 |
|
1,762 |
1,715 |
$69K |
| 99188 |
|
1,106 |
1,058 |
$68K |
| 11104 |
|
134 |
134 |
$67K |
| 71045 |
|
2,935 |
2,797 |
$66K |
| 76642 |
|
630 |
627 |
$65K |
| 80076 |
|
2,086 |
1,995 |
$64K |
| 36591 |
|
1,889 |
1,196 |
$64K |
| 86803 |
|
6,273 |
6,243 |
$64K |
| 96367 |
|
845 |
532 |
$63K |
| 87636 |
|
2,193 |
2,150 |
$60K |
| 82565 |
|
7,938 |
7,716 |
$60K |
| 92014 |
|
1,585 |
873 |
$59K |
| D9997 |
|
1,190 |
327 |
$59K |
| 90710 |
|
2,843 |
2,841 |
$59K |
| J1756 |
Injection, iron sucrose, 1 mg |
1,067 |
520 |
$58K |
| Q9992 |
Injection, buprenorphine extended-release (sublocade), greater than 100 mg |
26 |
24 |
$57K |
| 90750 |
|
410 |
407 |
$56K |
| 96160 |
|
1,263 |
1,262 |
$56K |
| 72148 |
|
158 |
158 |
$54K |
| 90707 |
|
2,336 |
2,330 |
$53K |
| A9585 |
Injection, gadobutrol, 0.1 ml |
2,518 |
1,520 |
$53K |
| 90471 |
|
30,200 |
29,772 |
$50K |
| 90619 |
|
1,750 |
1,537 |
$50K |
| 85610 |
|
7,333 |
5,269 |
$49K |
| 91322 |
|
611 |
610 |
$49K |
| 71260 |
|
134 |
134 |
$49K |
| 83735 |
|
12,056 |
9,842 |
$48K |
| 93226 |
|
272 |
270 |
$48K |
| 87389 |
|
5,451 |
5,425 |
$47K |
| 81003 |
|
20,668 |
19,117 |
$47K |
| 90716 |
|
2,137 |
2,133 |
$46K |
| 99443 |
|
495 |
389 |
$46K |
| 90732 |
|
952 |
938 |
$45K |
| 86580 |
|
3,003 |
2,826 |
$45K |
| V2020 |
Frames, purchases |
1,472 |
1,460 |
$45K |
| 97140 |
|
760 |
359 |
$44K |
| G0444 |
Annual depression screening, 5 to 15 minutes |
1,148 |
1,145 |
$44K |
| G9001 |
Coordinated care fee, initial rate |
580 |
580 |
$44K |
| 84450 |
|
6,647 |
6,524 |
$42K |
| 87522 |
Neg quan hep c or qual rna |
1,122 |
1,103 |
$42K |
| 87804 |
|
5,232 |
3,933 |
$42K |
| 73502 |
|
853 |
840 |
$41K |
| 88112 |
|
212 |
204 |
$41K |
| 90837 |
|
306 |
239 |
$41K |
| 81001 |
|
8,767 |
8,264 |
$41K |
| 87077 |
|
5,406 |
5,086 |
$40K |
| 90697 |
|
1,759 |
1,758 |
$40K |
| 84466 |
|
5,716 |
5,594 |
$39K |
| 99442 |
|
417 |
368 |
$39K |
| 95117 |
|
569 |
303 |
$39K |
| 84460 |
|
5,103 |
5,042 |
$39K |
| 90656 |
|
1,987 |
1,901 |
$39K |
| 0001A |
|
1,070 |
1,068 |
$39K |
| A4649 |
Surgical supply; miscellaneous |
1,472 |
216 |
$37K |
| 83690 |
|
6,438 |
6,088 |
$35K |
| 83880 |
|
1,134 |
1,039 |
$35K |
| 95909 |
|
188 |
188 |
$35K |
| 86140 |
|
5,961 |
5,754 |
$34K |
| 69209 |
|
631 |
621 |
$34K |
| 84484 |
|
3,460 |
2,913 |
$34K |
| 82746 |
|
3,295 |
3,276 |
$33K |
| 97161 |
|
328 |
328 |
$33K |
| 82570 |
|
6,631 |
6,462 |
$32K |
| 84702 |
|
3,216 |
2,741 |
$31K |
| 0002A |
|
818 |
816 |
$31K |
| 11720 |
|
801 |
782 |
$31K |
| 92133 |
|
560 |
557 |
$30K |
| 43235 |
|
41 |
41 |
$29K |
| 93922 |
|
382 |
379 |
$29K |
| 96415 |
|
76 |
54 |
$29K |
| 69210 |
|
426 |
420 |
$29K |
| 58300 |
|
208 |
205 |
$29K |
| 11042 |
|
83 |
65 |
$28K |
| 73140 |
|
590 |
576 |
$28K |
| 0071A |
|
772 |
772 |
$28K |
| 99381 |
|
167 |
165 |
$28K |
| 86618 |
|
4,212 |
4,169 |
$28K |
| 73080 |
|
659 |
612 |
$27K |
| 74018 |
|
862 |
839 |
$27K |
| 92587 |
|
586 |
585 |
$27K |
| 83540 |
|
7,079 |
6,937 |
$26K |
| 84520 |
|
6,171 |
5,145 |
$26K |
| 95886 |
|
502 |
502 |
$26K |
| 84480 |
|
3,215 |
3,171 |
$26K |
| 82043 |
|
5,634 |
5,600 |
$25K |
| 42820 |
|
12 |
12 |
$25K |
| 87070 |
|
5,148 |
4,911 |
$25K |
| 82948 |
|
5,459 |
3,419 |
$25K |
| 87653 |
|
493 |
489 |
$25K |
| 87340 |
|
3,591 |
3,561 |
$24K |
| 58100 |
|
53 |
53 |
$24K |
| 0072A |
|
653 |
653 |
$24K |
| 96523 |
|
475 |
403 |
$23K |
| 99383 |
|
177 |
177 |
$23K |
| J2469 |
Injection, palonosetron hcl, 25 mcg |
1,378 |
818 |
$23K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
1,255 |
1,096 |
$23K |
| 99386 |
|
185 |
185 |
$23K |
| 71250 |
|
41 |
41 |
$22K |
| 82330 |
|
1,954 |
1,872 |
$22K |
| 84403 |
|
1,549 |
1,526 |
$22K |
| 90620 |
|
709 |
709 |
$22K |
| 87186 |
|
4,545 |
4,284 |
$22K |
| 92083 |
|
344 |
341 |
$21K |
| 84153 |
|
2,613 |
2,590 |
$21K |
| G0145 |
Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, with screening by automated system and manual rescreening under physician supervision |
633 |
630 |
$21K |
| 70551 |
|
51 |
51 |
$20K |
| 54150 |
|
25 |
25 |
$20K |
| 81513 |
|
1,850 |
1,820 |
$20K |
| 82040 |
|
3,207 |
3,057 |
$20K |
| G0447 |
Face-to-face behavioral counseling for obesity, 15 minutes |
203 |
202 |
$19K |
| 86780 |
|
2,760 |
2,745 |
$19K |
| 82378 |
|
1,296 |
1,169 |
$19K |
| 94729 |
|
527 |
526 |
$18K |
| 17000 |
|
85 |
84 |
$18K |
| G0297 |
Low dose ct scan (ldct) for lung cancer screening |
69 |
69 |
$18K |
| 93242 |
|
121 |
118 |
$18K |
| 90747 |
|
253 |
249 |
$18K |
| 99441 |
|
151 |
141 |
$18K |
| 85652 |
|
6,167 |
5,987 |
$18K |
| 64721 |
|
13 |
13 |
$17K |
| 82947 |
|
3,656 |
3,623 |
$17K |
| 86762 |
|
2,103 |
2,098 |
$17K |
| 88307 |
|
163 |
136 |
$17K |
| 86666 |
|
3,789 |
2,173 |
$17K |
| 72050 |
|
338 |
337 |
$17K |
| 0124A |
|
484 |
484 |
$16K |
| 96376 |
|
1,228 |
803 |
$16K |
| 0054A |
|
427 |
426 |
$16K |
| 0064A |
|
433 |
433 |
$16K |
| 90480 |
|
613 |
613 |
$15K |
| 11102 |
|
30 |
30 |
$15K |
| 95908 |
|
107 |
107 |
$15K |
| 76817 |
|
136 |
117 |
$14K |
| D0120 |
|
340 |
198 |
$14K |
| 0202U |
|
249 |
249 |
$14K |
| J2704 |
Injection, propofol, 10 mg |
9,943 |
9,564 |
$14K |
| 86480 |
|
241 |
239 |
$13K |
| 84402 |
|
1,119 |
1,105 |
$13K |
| 92579 |
|
398 |
397 |
$13K |
| 90472 |
|
6,425 |
6,382 |
$13K |
| 90713 |
|
468 |
467 |
$12K |
| 73590 |
|
245 |
222 |
$12K |
| 84146 |
|
970 |
962 |
$12K |
| 83001 |
|
778 |
774 |
$12K |
| 87205 |
|
2,690 |
2,507 |
$12K |
| V2103 |
Spherocylinder, single vision, plano to plus or minus 4.00d sphere, .12 to 2.00d cylinder, per lens |
374 |
370 |
$12K |
| 99384 |
|
88 |
88 |
$11K |
| 94640 |
|
926 |
719 |
$11K |
| 82784 |
|
1,547 |
1,291 |
$11K |
| 96417 |
|
471 |
282 |
$11K |
| 72170 |
|
363 |
359 |
$11K |
| 0134A |
|
298 |
298 |
$11K |
| 0051A |
|
289 |
289 |
$10K |
| 31575 |
|
227 |
224 |
$10K |
| 88342 |
|
135 |
116 |
$10K |
| 87468 |
|
370 |
369 |
$10K |
| 85018 |
|
5,332 |
4,308 |
$10K |
| 80306 |
|
2,114 |
2,035 |
$10K |
| 82247 |
|
2,540 |
2,390 |
$10K |
| 83516 |
|
1,484 |
1,135 |
$10K |
| 86753 |
|
2,139 |
2,126 |
$10K |
| 0004A |
|
274 |
274 |
$10K |
| 97035 |
|
456 |
168 |
$10K |
| 85379 |
|
986 |
966 |
$9K |
| 11056 |
|
38 |
38 |
$9K |
| 82248 |
|
1,127 |
1,002 |
$9K |
| 87476 |
|
468 |
467 |
$9K |
| 92551 |
|
168 |
41 |
$9K |
| 90746 |
|
360 |
354 |
$9K |
| 82950 |
|
1,747 |
1,743 |
$9K |
| G0103 |
Prostate cancer screening; prostate specific antigen test (psa) |
270 |
270 |
$9K |
| 99382 |
|
69 |
69 |
$9K |
| 86706 |
|
1,241 |
1,228 |
$8K |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
10,277 |
9,622 |
$8K |
| 86787 |
|
1,723 |
1,712 |
$8K |
| 84550 |
|
1,860 |
1,707 |
$8K |
| 97535 |
|
231 |
199 |
$8K |
| 11721 |
|
136 |
136 |
$8K |
| 86003 |
|
395 |
392 |
$8K |
| 83615 |
|
2,490 |
2,253 |
$8K |
| 73090 |
|
231 |
213 |
$8K |
| 95816 |
|
39 |
39 |
$8K |
| 92552 |
|
186 |
186 |
$8K |
| 88720 |
|
1,774 |
1,300 |
$8K |
| 83520 |
|
1,012 |
995 |
$8K |
| 85014 |
|
917 |
843 |
$7K |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
4,937 |
4,820 |
$7K |
| 90696 |
|
397 |
397 |
$7K |
| 86769 |
|
271 |
270 |
$7K |
| 59430 |
|
730 |
727 |
$7K |
| 84100 |
|
2,104 |
1,881 |
$7K |
| 82550 |
|
1,307 |
1,219 |
$7K |
| 27096 |
|
12 |
12 |
$7K |
| J3490 |
Unclassified drugs |
329 |
318 |
$7K |
| 90847 |
|
38 |
30 |
$7K |
| 86431 |
|
1,525 |
1,516 |
$6K |
| 20550 |
|
27 |
25 |
$6K |
| 77334 |
|
13 |
12 |
$6K |
| 87469 |
|
371 |
370 |
$6K |
| 87478 |
|
370 |
369 |
$6K |
| 92250 |
|
93 |
92 |
$6K |
| 94726 |
|
38 |
38 |
$6K |
| 86704 |
|
924 |
917 |
$6K |
| 72125 |
|
27 |
27 |
$6K |
| 73562 |
|
98 |
96 |
$6K |
| 82150 |
|
1,301 |
1,279 |
$6K |
| 87484 |
|
370 |
369 |
$6K |
| 81220 |
|
29 |
29 |
$6K |
| 84132 |
|
1,798 |
1,490 |
$6K |
| 82533 |
|
395 |
365 |
$6K |
| 29075 |
|
29 |
26 |
$6K |
| 86038 |
|
1,467 |
1,446 |
$6K |
| 86308 |
|
657 |
648 |
$6K |
| D1110 |
|
83 |
70 |
$6K |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
36 |
36 |
$6K |
| 82310 |
|
1,927 |
1,778 |
$6K |
| 85730 |
|
1,448 |
1,367 |
$6K |
| 0052A |
|
144 |
144 |
$5K |
| 77300 |
|
18 |
15 |
$5K |
| J0690 |
Injection, cefazolin sodium, 500 mg |
2,334 |
2,116 |
$5K |
| 25600 |
|
12 |
12 |
$5K |
| C1713 |
Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) |
25 |
25 |
$5K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
8,217 |
7,051 |
$5K |
| 84155 |
|
2,017 |
1,972 |
$5K |
| 10060 |
|
13 |
13 |
$5K |
| 86376 |
|
635 |
633 |
$5K |
| 87040 |
|
581 |
345 |
$4K |
| 0011A |
|
119 |
119 |
$4K |
| 83605 |
|
1,243 |
1,109 |
$4K |
| 86617 |
|
596 |
363 |
$4K |
| C1769 |
Guide wire |
252 |
248 |
$4K |
| A9502 |
Technetium tc-99m tetrofosmin, diagnostic, per study dose |
292 |
288 |
$4K |
| 83721 |
|
1,123 |
1,110 |
$4K |
| G0296 |
Counseling visit to discuss need for lung cancer screening using low dose ct scan (ldct) (service is for eligibility determination and shared decision making) |
30 |
30 |
$4K |
| 77073 |
|
79 |
79 |
$4K |
| 84425 |
|
444 |
444 |
$3K |
| 90662 |
|
477 |
473 |
$3K |
| 83550 |
|
1,215 |
1,193 |
$3K |
| 90632 |
|
111 |
105 |
$3K |
| G0127 |
Trimming of dystrophic nails, any number |
89 |
78 |
$3K |
| 0031A |
|
112 |
110 |
$3K |
| 84156 |
|
979 |
896 |
$3K |
| 93246 |
|
26 |
26 |
$3K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
6,920 |
5,387 |
$3K |
| 84075 |
|
1,252 |
1,236 |
$3K |
| 87807 |
|
611 |
606 |
$3K |
| 86235 |
|
303 |
239 |
$3K |
| 80347 |
|
3,691 |
3,226 |
$3K |
| C1898 |
Lead, pacemaker, other than transvenous vdd single pass |
54 |
52 |
$3K |
| J1453 |
Injection, fosaprepitant, 1 mg |
67 |
41 |
$3K |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
6,803 |
6,206 |
$3K |
| 90647 |
|
101 |
101 |
$3K |
| 83993 |
|
155 |
154 |
$3K |
| 0081A |
|
89 |
89 |
$3K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
5,611 |
4,530 |
$3K |
| C9290 |
Injection, bupivacaine liposome, 1 mg |
39 |
39 |
$2K |
| 80326 |
|
3,690 |
3,225 |
$2K |
| 86592 |
|
955 |
952 |
$2K |
| 81329 |
|
55 |
55 |
$2K |
| 80364 |
|
3,690 |
3,225 |
$2K |
| 86765 |
|
326 |
325 |
$2K |
| 11055 |
|
14 |
14 |
$2K |
| 0154A |
|
80 |
80 |
$2K |
| 77065 |
Tomosynthesis, mammo |
24 |
24 |
$2K |
| 83002 |
|
164 |
162 |
$2K |
| C1760 |
Closure device, vascular (implantable/insertable) |
73 |
73 |
$2K |
| 86800 |
|
364 |
362 |
$2K |
| 82105 |
|
512 |
498 |
$2K |
| D0150 |
|
56 |
25 |
$2K |
| 82670 |
|
133 |
132 |
$2K |
| 58301 |
|
24 |
24 |
$2K |
| 86364 |
|
381 |
380 |
$2K |
| 0082A |
|
63 |
63 |
$2K |
| 81596 |
|
71 |
70 |
$2K |
| 86039 |
|
619 |
614 |
$2K |
| 86665 |
|
298 |
165 |
$2K |
| J2795 |
Injection, ropivacaine hydrochloride, 1 mg |
1,801 |
1,593 |
$2K |
| 97116 |
|
49 |
37 |
$2K |
| J1642 |
Injection, heparin sodium, (heparin lock flush), per 10 units |
4,910 |
2,783 |
$2K |
| 93880 |
|
12 |
12 |
$2K |
| 87493 |
|
197 |
192 |
$2K |
| 99407 |
|
68 |
68 |
$2K |
| 82274 |
|
368 |
367 |
$2K |
| 81511 |
|
39 |
39 |
$2K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
7,279 |
6,643 |
$2K |
| 76882 |
|
29 |
28 |
$2K |
| 94761 |
|
282 |
202 |
$2K |
| A9500 |
Technetium tc-99m sestamibi, diagnostic, per study dose |
39 |
39 |
$2K |
| 92341 |
|
25 |
25 |
$2K |
| 67028 |
|
12 |
12 |
$2K |
| 72082 |
|
25 |
25 |
$1K |
| 90685 |
|
76 |
74 |
$1K |
| J7050 |
Infusion, normal saline solution, 250 cc |
2,661 |
1,906 |
$1K |
| 84165 |
|
557 |
544 |
$1K |
| 82977 |
|
275 |
253 |
$1K |
| 80164 |
|
118 |
113 |
$1K |
| 90381 |
|
53 |
53 |
$1K |
| C1887 |
Catheter, guiding (may include infusion/perfusion capability) |
91 |
83 |
$1K |
| J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) |
2,972 |
1,947 |
$1K |
| D1206 |
|
42 |
42 |
$1K |
| 85045 |
|
393 |
387 |
$1K |
| J0689 |
Injection, cefazolin sodium (baxter), not therapeutically equivalent to j0690, 500 mg |
921 |
846 |
$1K |
| 11200 |
|
16 |
13 |
$1K |
| 86200 |
|
204 |
204 |
$1K |
| 84160 |
|
558 |
545 |
$1K |
| J1030 |
Injection, methylprednisolone acetate, 40 mg |
345 |
337 |
$1K |
| J2785 |
Injection, regadenoson, 0.1 mg |
38 |
38 |
$1K |
| G0008 |
Administration of influenza virus vaccine |
256 |
255 |
$982.79 |
| 86870 |
|
15 |
14 |
$973.53 |
| 86708 |
|
102 |
101 |
$970.21 |
| 86664 |
|
165 |
165 |
$896.46 |
| 97530 |
|
23 |
15 |
$890.52 |
| 90744 |
|
43 |
43 |
$800.07 |
| 92340 |
|
13 |
13 |
$799.11 |
| 72100 |
|
15 |
15 |
$762.90 |
| J3475 |
Injection, magnesium sulfate, per 500 mg |
1,009 |
687 |
$756.74 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
5,417 |
5,309 |
$744.41 |
| J3420 |
Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg |
2,200 |
1,717 |
$696.11 |
| 80349 |
|
1,289 |
1,242 |
$688.83 |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
1,362 |
1,067 |
$638.48 |
| 87529 |
|
19 |
15 |
$628.25 |
| 86225 |
|
166 |
166 |
$623.17 |
| J1170 |
Injection, hydromorphone, up to 4 mg |
1,684 |
1,502 |
$613.95 |
| 80178 |
|
81 |
79 |
$607.16 |
| 0083A |
|
18 |
18 |
$596.68 |
| 96411 |
|
19 |
12 |
$587.07 |
| 80377 |
|
1,879 |
1,792 |
$554.48 |
| 0012A |
|
14 |
14 |
$491.95 |
| 73660 |
|
13 |
13 |
$488.10 |
| 86735 |
|
95 |
86 |
$470.38 |
| J1644 |
Injection, heparin sodium, per 1000 units |
1,138 |
705 |
$468.82 |
| 91321 |
|
49 |
49 |
$455.61 |
| 0074A |
|
23 |
23 |
$452.01 |
| G0379 |
Direct admission of patient for hospital observation care |
25 |
24 |
$433.82 |
| J7042 |
5% dextrose/normal saline (500 ml = 1 unit) |
884 |
579 |
$431.89 |
| 0053A |
|
12 |
12 |
$420.45 |
| V2784 |
Lens, polycarbonate or equal, any index, per lens |
49 |
49 |
$396.35 |
| J2371 |
Injection, phenylephrine hydrochloride, 20 micrograms |
555 |
504 |
$337.45 |
| J2543 |
Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams) |
34 |
25 |
$316.51 |
| J2370 |
Injection, phenylephrine hcl, up to 1 ml |
1,118 |
1,108 |
$314.86 |
| J1010 |
Injection, methylprednisolone acetate, 1 mg |
139 |
123 |
$313.75 |
| J0665 |
Injection, bupivicaine, not otherwise specified, 0.5 mg |
937 |
810 |
$313.47 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
797 |
610 |
$305.02 |
| 88142 |
|
12 |
12 |
$295.76 |
| 87625 |
|
95 |
95 |
$292.74 |
| 92555 |
|
13 |
13 |
$286.00 |
| 17003 |
|
12 |
12 |
$281.07 |
| 86160 |
|
20 |
13 |
$274.20 |
| 64494 |
|
12 |
12 |
$262.74 |
| 86300 |
|
30 |
25 |
$245.70 |
| J7060 |
5% dextrose/water (500 ml = 1 unit) |
832 |
600 |
$245.28 |
| 88302 |
|
19 |
13 |
$241.15 |
| 87075 |
|
26 |
24 |
$222.43 |
| 71101 |
|
12 |
12 |
$201.95 |
| 84481 |
|
25 |
24 |
$199.37 |
| 80329 |
|
772 |
737 |
$181.14 |
| 82272 |
|
66 |
66 |
$178.58 |
| 83883 |
|
22 |
12 |
$170.80 |
| 82374 |
|
88 |
86 |
$159.61 |
| 80177 |
|
24 |
24 |
$157.45 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
1,129 |
851 |
$155.61 |
| J1650 |
Injection, enoxaparin sodium, 10 mg |
712 |
373 |
$140.96 |
| J1598 |
Injection, glycopyrrolate (fresenius kabi), not therapeutically equivalent to j1596, 0.1 mg |
227 |
143 |
$136.71 |
| 84590 |
|
25 |
25 |
$131.22 |
| 84597 |
|
13 |
13 |
$128.12 |
| J0136 |
Injection, acetaminophen (b braun), not therapeutically equivalent to j0131, 10 mg |
158 |
146 |
$120.98 |
| 96380 |
|
16 |
16 |
$120.90 |
| 84295 |
|
28 |
28 |
$117.53 |
| 81015 |
|
99 |
99 |
$115.04 |
| 87102 |
|
28 |
27 |
$111.63 |
| J1643 |
Injection, heparin sodium (pfizer), not therapeutically equivalent to j1644, per 1000 units |
96 |
51 |
$107.21 |
| 84446 |
|
13 |
13 |
$96.82 |
| J1596 |
Injection, glycopyrrolate, 0.1 mg |
148 |
148 |
$95.99 |
| 80320 |
|
1,051 |
995 |
$89.94 |
| A9270 |
Non-covered item or service |
348 |
195 |
$77.75 |
| 84630 |
|
13 |
12 |
$75.00 |
| 84202 |
|
12 |
12 |
$72.72 |
| 86696 |
|
12 |
12 |
$57.59 |
| 86255 |
|
16 |
13 |
$55.18 |
| J0702 |
Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg |
14 |
13 |
$54.66 |
| 86695 |
|
12 |
12 |
$48.85 |
| Q0162 |
Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen |
304 |
264 |
$46.04 |
| J2272 |
Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg |
84 |
65 |
$45.26 |
| 82465 |
|
16 |
16 |
$39.23 |
| J0131 |
Injection, acetaminophen, not otherwise specified,10 mg |
53 |
51 |
$38.50 |
| J1171 |
Injection, hydromorphone, 0.1 mg |
36 |
17 |
$33.48 |
| J0736 |
Injection, clindamycin phosphate, 300 mg |
22 |
21 |
$25.42 |
| J0137 |
Injection, acetaminophen (hikma), not therapeutically equivalent to j0131, 10 mg |
14 |
14 |
$15.81 |
| 82435 |
|
25 |
25 |
$14.66 |
| J2003 |
Injection, lidocaine hydrochloride, 1 mg |
353 |
305 |
$14.52 |
| J2004 |
Injection, lidocaine hcl with epinephrine, 1 mg |
88 |
83 |
$12.71 |
| 94664 |
|
66 |
36 |
$12.40 |
| 87210 |
|
12 |
12 |
$10.89 |
| J0737 |
Injection, clindamycin phosphate (baxter), not therapeutically equivalent to j0736, 300 mg |
15 |
15 |
$9.61 |
| J2001 |
Injection, lidocaine hcl for intravenous infusion, 10 mg |
27 |
27 |
$8.37 |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
46 |
41 |
$5.58 |
| J7620 |
Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme |
37 |
33 |
$2.48 |
| J2550 |
Injection, promethazine hcl, up to 50 mg |
14 |
14 |
$2.17 |
| 99495 |
|
24 |
24 |
$0.00 |
| 92002 |
|
12 |
12 |
$0.00 |
| 80323 |
|
29 |
24 |
$0.00 |
| G1004 |
Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program |
51 |
49 |
$0.00 |
| 99203 |
|
17 |
17 |
$0.00 |